| 12/22/2017 | Becoming a substantial holder | PDF | 2017 |
| 12/21/2017 | Initial directors interest notice | PDF | 2017 |
| 12/21/2017 | Final directors interest notice | PDF | 2017 |
| 12/20/2017 | Appointment of Niall Cairns | PDF | 2017 |
| 12/15/2017 | AtCor Medical secures new $1m pharmaceutical contract | PDF | 2017 |
| 12/05/2017 | Initial directors interest notice | PDF | 2017 |
| 12/05/2017 | Final directors interest notice | PDF | 2017 |
| 11/30/2017 | Results of meeting | PDF | 2017 |
| 11/30/2017 | Chairman’s address | PDF | 2017 |
| 11/30/2017 | AtCor Medical appoints Craig Cooper as CEO | PDF | 2017 |
| 11/15/2017 | Craig Cooper to join AtCor Medical Board | PDF | 2017 |
| 10/30/2017 | Tax refund | PDF | 2017 |
| 10/27/2017 | Notice of annual general meeting | PDF | 2017 |
| 10/27/2017 | Appendix 4G corporate governance | PDF | 2017 |
| 09/29/2017 | Change of directors interest notice | PDF | 2017 |
| 09/22/2017 | Completion of share purchase plan | PDF | 2017 |
| 09/22/2017 | Appendix 3B | PDF | 2017 |
| 09/14/2017 | Viking Yacht adds SphygmoCor for employee wellness | PDF | 2017 |
| 09/05/2017 | Security purchase plan | PDF | 2017 |
| 08/31/2017 | Full year statutory accounts | PDF | 2017 |
| 08/29/2017 | Share purchase plan | PDF | 2017 |
| 08/16/2017 | Cleansing notice | PDF | 2017 |
| 08/15/2017 | Appendix 3B | PDF | 2017 |
| 08/08/2017 | Share placement | PDF | 2017 |
| 08/04/2017 | Trading halt | PDF | 2017 |
| 08/02/2017 | AtCor Medical Restructures Operations | PDF | 2017 |
| 07/31/2017 | AtCor Medical signs new agreement | PDF | 2017 |
| 07/12/2017 | AtCor Medical secures $0.8 million in new pharmaceutical contract | PDF | 2017 |
| 06/07/2017 | AtCor Medical signs new network health system agreement | PDF | 2017 |
| 05/18/2017 | Business update and strategic review | PDF | 2017 |
| 02/24/2017 | Half yearly reports and accounts | PDF | 2017 |
| 02/23/2017 | AtCor Medical signs local health system agreement | PDF | 2017 |
| 02/16/2017 | Study on central aortic waveform in heart failure | PDF | 2017 |
| 02/14/2017 | Tax refund | PDF | 2017 |
| 01/25/2017 | Central blood pressure and cognitive decline | PDF | 2017 |
| 01/23/2017 | Positive Novartis drug trial using SphygmoCor | PDF | 2017 |
| 08/31/2018 | CardieX appendix 4E and 2018 annual financial statements | PDF | 2018 |
| 08/29/2018 | Becoming a substantial holder | PDF | 2018 |
| 08/28/2018 | Appendix 3B | PDF | 2018 |
| 07/24/2018 | CardieX reports successful trial results for wearable sensor | PDF | 2018 |
| 07/04/2018 | Form 604 – change in substantial holding | PDF | 2018 |
| 07/03/2018 | CardieX restructure and new executive appointments | PDF | 2018 |
| 06/19/2018 | CardieX makes first investment in wearable tech partnership | PDF | 2018 |
| 06/18/2018 | CardieX commences trading under new code ASX_CDX | PDF | 2018 |
| 06/15/2018 | Appendix 3B | PDF | 2018 |
| 06/12/2018 | CardieX (AtCor Medical) entitlements issue heavily over subscribed | PDF | 2018 |
| 06/05/2018 | Appendix 3Y – O’Dwyer | PDF | 2018 |
| 06/05/2018 | Appendix 3B | PDF | 2018 |
| 06/01/2018 | Appendix 3Y – Cooper | PDF | 2018 |
| 06/01/2018 | Appendix 3Y – Cairns | PDF | 2018 |
| 06/01/2018 | Appendix 3B | PDF | 2018 |
| 05/31/2018 | Revised timing on trade commencement | PDF | 2018 |
| 05/30/2018 | Change of name to CardieX Limited | PDF | 2018 |
| 05/28/2018 | Results of EGM | PDF | 2018 |
| 05/03/2018 | Despatch of underwritten rights issue prospectus | PDF | 2018 |
| 05/01/2018 | Completion of placement and notice under s708A | PDF | 2018 |
| 05/01/2018 | Appendix 3B – completion of placement | PDF | 2018 |
| 04/30/2018 | Notice of EGM and proxy despatched | PDF | 2018 |
| 04/26/2018 | Letter to ineligible shareholders | PDF | 2018 |
| 04/26/2018 | Letter to eligible shareholders | PDF | 2018 |
| 04/24/2018 | Appendix 3B – entitlements issue | PDF | 2018 |
| 04/23/2018 | Underwritten rights issue prospectus lodged with ASIC | PDF | 2018 |
| 04/23/2018 | Over subscribed capital raising to fast track strategy | PDF | 2018 |
| 04/19/2018 | Trading halt | PDF | 2018 |
| 04/05/2018 | Final directors interest notice – D Brookes | PDF | 2018 |
| 04/03/2018 | Change to board of directors | PDF | 2018 |
| 03/14/2018 | AtCor Medical announces first step in major strategic repositioning | PDF | 2018 |
| 03/06/2018 | Resignation of CFO and company secretary | PDF | 2018 |
| 02/28/2018 | Half yearly report and accounts | PDF | 2018 |
| 01/23/2018 | AtCor Medicals’ XCEL device clinically validated in third party study | PDF | 2018 |
| 01/18/2018 | AtCor Medical and PhysioAge Systems announce supply agreement | PDF | 2018 |
| 06/05/2019 | CDX Achieves Major Milestone in Wearable Sensor Development | PDF | 2019 |
| 12/06/2018 | CardieX Successfully Closes Oversubscribed $5.5m Fundraising | PDF | 2018 |
| 12/12/2018 | CardieX Signs Agreement for Wearable Sensor Development | PDF | 2018 |
| 12/14/2018 | Appendix 3B | PDF | 2018 |
| 12/18/2018 | CardieX’s inHealth Signs LOI With Global Electronics Company | PDF | 2018 |
| 12/19/2018 | Cleansing Notice Under s708A(5)(e) | PDF | 2018 |
| 12/19/2018 | Notice Under ASX Listing Rule 3.10.5A | PDF | 2018 |
| 01/11/2019 | Top 20 Shareholders | PDF | 2019 |
| 01/14/2019 | Top 20 and Capital Structure | PDF | 2019 |
| 01/15/2019 | Cardiex’s inHealth Executes Major Co-Marketing Agreement | PDF | 2019 |
| 01/18/2019 | Response to ASX Aware Query | PDF | 2019 |
| 01/22/2019 | Convertible Note Application Received from C2 Ventures | PDF | 2019 |
| 01/25/2019 | Notice of Extraordinary General Meeting/Proxy Form | PDF | 2019 |
| 01/25/2019 | CardieX Despatches Notice of EGM to Shareholders | PDF | 2019 |
| 01/30/2019 | CardieX Progress Summary & CEO Outlook | PDF | 2019 |
| 02/01/2019 | CardieX Update on the Acquisition of 50.5% of inHealth | PDF | 2019 |
| 02/04/2019 | Transition of Chairman Role | PDF | 2019 |
| 02/04/2019 | CardieX Technology Validated in Chinese Clinical Study | PDF | 2019 |
| 02/21/2019 | Achievement of First CEO Performance Rights Hurdle | PDF | 2019 |
| 02/26/2019 | Senior Health Executive Appointed to Cardiex Advisory Board | PDF | 2019 |
| 02/26/2019 | Results of Extraordinary General Meeting | PDF | 2019 |
| 02/27/2019 | Final Director’s Interest Notice | PDF | 2019 |
| 02/27/2019 | Transition of Directors & New Interim Chairman Appointment | PDF | 2019 |
| 02/28/2019 | Half Year Accounts | PDF | 2019 |
| 02/28/2019 | Appendix 4D Half Year Report | PDF | 2019 |
| 03/06/2019 | CardieX Announces Expansion of Bayer Pharma Trial Contract | PDF | 2019 |
| 03/06/2019 | Appendix 3B | PDF | 2019 |
| 03/12/2019 | CardieX China and Product Strategy Update – English | PDF | 2019 |
| 04/01/2019 | CardieX Corporate Update and Report from CEO | PDF | 2019 |
| 04/02/2019 | CardieX and inHealth Collaboration in Landmark US Study | PDF | 2019 |
| 04/16/2019 | Appendix 3B | PDF | 2019 |
| 04/23/2019 | Oscar 2 Medical Device Receives China FDA Approval | PDF | 2019 |
| 05/20/2019 | CDX & inHealth Sign MOU with Major Chinese Telemed Company | PDF | 2019 |
| 05/21/2019 | CardieX Establishes Local Operations in China | PDF | 2019 |
| 05/22/2019 | s604 and Change in Director’s Interest Notices | PDF | 2019 |
| 05/24/2019 | CDX & Blumio Present Successful Trial Results at IEEE | PDF | 2019 |
| 05/28/2019 | inHealth Delivers on Rapid Growth Expectations | PDF | 2019 |
| 06/04/2019 | Wearables & Blumio Update from CEO of CardieX | PDF | 2019 |
| 05/29/2019 | Senior Healthcare Executive Rhonda Welch Appointed Vice President of Global Marketing | PDF | 2019 |
| 05/20/2019 | CardieX and inHealth Collaborate on Pilot Program with Leading Chinese Telemedicine Platform Health160 to Deploy inHealth Solutions Across China | PDF | 2019 |
| 05/21/2018 | AtCor Medical announces wearable trial with Macquarie University | PDF | 2018 |
| 05/21/2018 | Blumio wearable cardio trial with Macquarie University | PDF | 2018 |
